These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 85373)

  • 1. [Liver function studies under the effect of 4 sequential hormonal contraceptives].
    Brügmann E; Göretzlehner G; Klie E; Schwager A; Maass M
    Z Gesamte Inn Med; 1978 Nov; 33(22):826-9. PubMed ID: 85373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Liver function tests under the influence of sequential treatment using ethinyl estradiol-norethisterone acetate and ethinyl estradiol-chlormadinone acetate].
    Akpowowo HE; Göretzlehner G; Brügmann E; Töwe J
    Zentralbl Gynakol; 1976; 98(19):1198-203. PubMed ID: 62469
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Liver function studies under the influence of hormonal contraceptives (sequential preparations)].
    Brügmann E; Göretzlehner G; Dabels J; Töwe J
    Dtsch Z Verdau Stoffwechselkr; 1979; 39(2):69-74. PubMed ID: 88322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on liver functions under the effect of sequence drugs.
    Brugmann E; Töwe J; Dummler W
    Mater Med Pol; 1979; 11(1):47-50. PubMed ID: 480980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on liver function under the influence of oral contraceptives.
    Brügmann E; Göretzlehner G; Dabels J; Töwe J
    Int J Gynaecol Obstet; 1979; 16(5):394-7. PubMed ID: 86470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Liver function tests after a 6-month deposiston therapy].
    Brügmann E; Göretzlehner G; Töwe J; Rehpenning W
    Zentralbl Gynakol; 1975; 97(11):669-73. PubMed ID: 1189758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A gradual method for a more physiological hormonal contraception].
    Hamann B; Büchner C
    Zentralbl Gynakol; 1976; 98(23):1445-9. PubMed ID: 65068
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Provisional results of a clinical study of sequential and combination therapy with oral contraceptives].
    Arnold M; Angst-Horridge A; Burckhardt-Tamm E; Cloeren S; Mall-Haefeli M; Richter RH; Streit-Pfenniger M; Wyss H
    Gynaecologia; 1968; 165(2):218-20. PubMed ID: 4178566
    [No Abstract]   [Full Text] [Related]  

  • 9. The serum alanine aminotransferase activity and the two-hour sulphobromophthalein retention test during daily low-dose gestagen oral contraceptive treatment.
    Larsson-Cohn U
    Acta Soc Med Ups; 1969; 74(5-6):283-8. PubMed ID: 4192336
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Modification of serum lipids and glucose tolerance by sequential Ovosiston and Minisiston].
    Vesper VB; Feustel S
    Zentralbl Gynakol; 1988; 110(4):241-5. PubMed ID: 2453102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Radioimmunological study of the effect of hormonal contraceptives upon the progesterone level of saliva (author's transl)].
    Arnold M; Tóth I; Faredin I
    Zahn Mund Kieferheilkd Zentralbl; 1980; 68(7):713-8. PubMed ID: 6163264
    [No Abstract]   [Full Text] [Related]  

  • 12. [Two-stage therapy as a method of hormonal contraception in comparison with compound preparations].
    Rothe K
    Z Gesamte Hyg; 1970 Apr; 16(4):289-90. PubMed ID: 4108397
    [No Abstract]   [Full Text] [Related]  

  • 13. [Hormonal contraception--side effects and surgical aspects (author's transl)].
    Göretzlehner G; Carol W; Köhler G
    Zentralbl Chir; 1980; 105(24):1601-16. PubMed ID: 7015744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Has low-dosage therapy with the oral contraceptive Ovosiston any effect on glucose tolerance and liver function?].
    Heller H; Canzler E
    Z Gesamte Inn Med; 1970 Oct; 25(20):936-40. PubMed ID: 4106958
    [No Abstract]   [Full Text] [Related]  

  • 15. Sequential mestranol-chlormadinone acetate as an oral contraceptive.
    Tyler ET
    Obstet Gynecol; 1966 Dec; 28(6):787-92. PubMed ID: 4162518
    [No Abstract]   [Full Text] [Related]  

  • 16. [Rationale for prescribing oral contraceptives].
    Teichmann AT
    Wien Med Wochenschr; 1998; 148(7):171-4. PubMed ID: 9700865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The action of Sequostat in comparison to Sequence Ovosiston on selected metabolic parameters].
    Etzrodt R; Klinger G; Carol W
    Zentralbl Gynakol; 1990; 112(8):489-96. PubMed ID: 1694614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Effect of oral contraceptives on the psyche and on sexuality].
    Nahrendorf G; Carol W; Klinger G
    Zentralbl Gynakol; 1978; 100(10):632-7. PubMed ID: 79278
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of a sequential-type oral contraceptive with ethinylestradiol-sulfonate soft gelatin capsules and norethisterone acetate on carbohydrate metabolism during the first twelve months.
    Nikschick S; Göretzlehner G; Männchen E; Brachmann K
    Exp Clin Endocrinol; 1985 Jun; 85(3):257-62. PubMed ID: 3899684
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transcortin as an indicator of estrogenic potency in oral contraceptives.
    Carol W; Börner A; Klinger G; Greinke C
    Endokrinologie; 1980 Mar; 75(2):167-72. PubMed ID: 6156820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.